IBA Proton Therapy shared a post on LinkedIn:
“Proud to see our colleague Mauro A. Ferreira (Vice President of Sales – Latin America and the Caribbean at IBA Proton Therapy) featured on OncoDaily discussing the future of pediatric cancer care in Brazil.
In the piece, Mauro highlights Brazil’s growing momentum around proton therapy – especially its potential to improve outcomes for children with cancer. He points to recent clinical and economic evidence from studies led by Prof. Gustavo Viani from the University of Vassouras and collaborators (including promise, cure, propel) that strengthen the case for wider adoption of this advanced radiotherapy approach.
A great spotlight on how clinical leadership and research can help shape meaningful progress in cancer treatment.”
Other articles featuring IBA Proton Therapy on OncoDaily.